The main culprit, LDL (for low-density lipoprotein), is the body's oil truck, circulating in the blood, delivering fat and cholesterol to the cells.
主要的“罪犯”是低密度脂蛋白胆固醇，它是身体的运油车，在血液里向细胞传输脂肪和胆固醇。
Because the second kind, low-density lipoprotein (LDL), get smaller and smaller until they're tiny enough to enter the walls of your blood vessels and attach themselves like a bad houseguest.
因为还有第二种胆固醇，即低密度脂蛋白(LDL) LD L变得越来越小直到他们足够小能进入血管壁，然后依附在血管壁上。
Following a lifestyle that decreases LDL (low-density lipoprotein) and increases HDL (high-density lipoprotein) is the primary path to lower cholesterol.
在日常生活中，人们一般把降低低密度脂蛋白ldl和增加高密度脂蛋白hdl当作是降低胆固醇的主要的路径。
Doctors have known for years that HDL, or high-density lipoprotein, protects against heart attacks and stroke, probably by cleaning up the bad low-density lipoprotein cholesterol, known as LDL.
医生多年前已经知道高密度脂蛋白(HDL)可以通过清除不良的低密度脂蛋白胆固醇(即已知的LDL)来保护对抗心脏病发作和心肌梗塞。
There are three kinds of blood cholesterol that you should know about: high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides.
对三种血胆固醇你应该了解：高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和甘油三酯。
Research scientists suspect that various oxidised forms of what is known as bad cholesterol, LDL (low-density lipoprotein), contribute to the development of the disease.
科学家们怀疑多种氧化方式的低密度脂蛋白导致了这种疾病的发生，低密度脂蛋白被人们称之为坏胆固醇。
Statins work by lowering the production of cholesterol by the liver, and are most effective at reducing low-density lipoprotein, or LDL, the so-called bad cholesterol.
他汀类药物通过降低肝脏产生的胆固醇而发挥作用，并且在降低低密度脂蛋白或LDL（所谓的坏胆固醇）方面最为有效。
HDL lowers heart risks because it clears low-density lipoprotein, or LDL cholesterol, away from arteries and back to the liver, where it is passed out of the body.
HDL可降低心脏病风险，因为它清除了低密度脂蛋白，后者也称为LDL胆固醇，它离开动脉后返回到肝脏，在那里被清除出体外。
Objective To appraise the property of low density lipoprotein cholesterol (LDL-C) direct test reagents.
目的评价低密度脂蛋白胆固醇(LDL - C)直接法检测试剂性能指标。
Aim to explore the effect of oxidized low density lipoprotein (ox LDL) on cholesterol accumulation in mouse peritoneal macrophages and its relationship with activity of lysosomal cathepsin.
研究氧化型低密度脂蛋白对小鼠腹腔巨噬细胞胆固醇蓄积的影响，并探讨其与组织蛋白酶活性之间的关系。
The levels of serum total cholesterol (TC), low density lipoprotein cholesterol (LDL-C) and triglyceride (TG) in hypertension group were higher than normal control.
同时高血压组总胆固醇（TC）、低密度脂蛋白胆固醇（LDL-C）、甘油三酯（TG）水平明显高于正常血压组。
Objective To study the prognostic value of low density lipoprotein cholesterol(LDL C) on left ventricular systolic function in patients with first acute myocardial infarction.
目的探讨低密度脂蛋白胆固醇（LDLC）对首次急性心肌梗死后左室收缩功能的预测价值。
Plasma cholesterol and low-density lipoprotein (LDL) were elevated with a normal triglyceride level.
血浆胆固醇和低密度脂蛋白升高，甘油三酯正常。
Objective To investigate correlation between oxidatively modified low density lipoprotein (OX-LDL), serum ferritin (SF) and the severity of coronary artery lesion.
目的探讨血浆氧化修饰低密度脂蛋白（OX -LDL）及血清铁蛋白（SF）与冠状动脉病变程度的关系。
Lower HDL and higher low-density lipoprotein (LDL) cholesterol were significantly associated with ischemic heart disease in patients younger than 65 years of age, the authors report.
研究者报告称，在年龄小于65岁的患者较低的高密度脂蛋白水平及较高的低密度脂蛋白水平与缺血性心脏病显著相关。
Objective to investigate the effects of oxidized low-density lipoprotein receptor 1 (LOX-1) on secretion of adhesive molecules mediated by ox-LDL in human umbilical endothelial cells (HUVECs).
目的探讨血凝素样氧化低密度脂蛋白受体1 (LOX - 1)在氧化低密度脂蛋白(ox - LDL)诱导血管内皮细胞粘附分子表达中的作用。
The use of quartz crystal microbalance(QCM) for monitoring in situ the adsorption of low-density lipoprotein(LDL) onto cholesterol modified dextran(CMD) was described. The kinetic studies were made.
利用石英晶体微天平实时监测低密度脂蛋白（LDL）在胆固醇修饰葡聚糖（CMD）上的吸附，并对其吸附动力学进行研究。
Soya beans: Several studies have confirmed that consumption of soy products can reduce low-density lipoprotein (LDL), known as the bad cholesterol, and help strengthen the heart.
黄豆：数项研究证实食用黄豆可减少低密度脂蛋白，亦即所谓坏脂蛋白，而有助于强化心脏。
Plasma total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein (HDL) were estimated by enzymatic method.
采用酶法观测空腹总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白(HDL)及低密度脂蛋白胆固醇(LDL - C)的变化。
Methods The contents of total cholesterol(TC), triglyceride(TG), high density lipoprotein(HDL), low density lipoprotein(LDL) in blood were determined and analyzed.
方法采用常规抗血脂作用的方法，测定血液中总胆固醇、 甘油三酯、高密度脂蛋白、低密度脂蛋白的含量。
Early glycated low density lipoprotein (LDL) was not recognized by this receptor. AGEP BSA elevated cytosolic free calcium in a concentration dependent manner.
通过该受体介导，平滑肌细胞可内化、代谢AGEP．AGEP使胞浆游离钙呈浓度依赖性升高；
Objective:To study one kind of rapid and plenty method of isolating the subfractions of low density lipoprotein (LDL).
目的：研究快速大量分离低密度脂蛋白亚组分的方法。
These people had an average reduction in total blood cholesterol concentration of 5.1%, and a reduction in low-density lipoprotein, or so-called LDL or "bad" cholesterol, of 7.4%.
这组人血液中胆固醇总浓度有平均5.1%的下降，低密度脂蛋白或是LDL或是“有害的”胆固醇也下降了7.4%。
Low-density lipoprotein (LDL) cholesterol is one component of this overall number.
低密度脂蛋白是胆固醇总量中的一个组成部分。
For instance, familial hypercholesterolemia (FH) typically results from mutations in LDLR encoding the low-density lipoprotein (LDL) receptor.
例如，家族性血胆脂醇过多症(FH)通常起源于编码低密度脂蛋白(LDL)受体的LDLR突变。
This invention relates to a highly efficient artificial low-density lipoprotein (LDL) carrier system for the targeted delivery therapeutic agents across the blood-brain barrier (BBB).
本发明涉及用于靶向传递治疗剂穿过血脑屏障(BBB)的高效人工低密度脂蛋白(LDL)载体体系。
This invention relates to a highly efficient artificial low-density lipoprotein (LDL) carrier system for the targeted delivery therapeutic agents across the blood-brain barrier (BBB).
本发明涉及用于靶向传递治疗剂穿过血脑屏障(BBB)的高效人工低密度脂蛋白(LDL)载体体系。
应用推荐